Latest Leverage News

Turners Automotive Group has posted a record $63.2 million normalised NPBT for FY26, advancing its $65 million NPBT target to FY27 and setting sights on $100 million by FY31 amid solid finance and retail momentum.

BLIS Technologies posted a 16% revenue increase to $14.7 million in FY26, resolving a key intellectual property dispute and expanding strategic partnerships, including an extended Probi AB agreement that now covers pet nutrition.

Investore Property Limited reported a resilient FY26 with 14% portfolio growth driven by acquisitions, maintained dividends, and proactive capital management amid inflationary pressures.

InvestSMART Group Limited (ASX:INV) has agreed to sell its Intelligent Investor business and management rights to four ETFs to Teaminvest Private Group Limited (ASX:TIP) for $16 million, aiming to sharpen its focus on digital advice and wealth platforms.

OD6 Metals is progressing its acquisition option for the Quinn Fluorspar Project in Nevada, a high-grade fluorspar asset poised to address the United States' complete import reliance on this critical mineral vital to semiconductor, battery, and defense sectors.

Gibb River Diamonds has released the results of its initial aircore drilling program at the Edjudina Gold Project, revealing gold mineralisation of lower than expected grades but confirming key target geology. Inclement weather cut the program short, prompting a follow-up Phase 2 drilling campaign.

Gold Hydrogen is accelerating Helium development at its Ramsay Project, leveraging exceptional purity results and independent modelling amid a tightening global Helium supply.

Flagship Minerals has secured A$2.75 million through a strategic placement led by long-term partners, poised to accelerate feasibility and technical work at its 2.1 million ounce Isidora Gold Project in Chile.

RAS Technology Holdings has locked in new contracts and extensions expected to add at least $2 million in annualised revenue, reinforcing growth in wagering technology and international markets.

Close the Loop Limited has sold its ISP Tek Services business for US$10 million, slashed US$16 million of debt, and set an optimistic EBITDA target of $14 million to $16 million for FY27, signalling a sharper focus on its packaging and resource recovery strengths.

Patrys has appointed CMAX and Alithia Life Sciences to lead its Phase 1A clinical trial operations for RLS-2202, advancing its injectable quetiapine program toward first-in-human testing in Q3 2026, pending ethics approval.

Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.